Article info
Extended essay
Nudges in a post-truth world
- Correspondence to Professor Neil Levy, Department of Philosophy, Macquarie University, Sydney, NSW 2109, Australia; neil.levy{at}philosophy.ox.ac.uk
Citation
Nudges in a post-truth world
Publication history
- Received January 12, 2017
- Revised April 4, 2017
- Accepted April 18, 2017
- First published May 19, 2017.
Online issue publication
July 26, 2017
Article Versions
- Previous version (19 May 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Other content recommended for you
- Public health for paediatricians:How can behavioural economics help to make paediatric practice more effective?
- Weapons of mass destruction—threats and responses
- The challenges and opportunities of ‘nudging’
- Public health nudges: weighing individual liberty and population health benefits
- Too little, too late: social media companies’ failure to tackle vaccine misinformation poses a real threat
- Is all fair in biological warfare? The controversy over genetically engineered biological weapons
- Vaccine disputes
- Nudges to reason: not guilty
- Influence of political and medical leaders on parental perception of vaccination: a cross-sectional survey in Australia
- Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR